Joel Greenblatt Procept Bio Robotics Corp Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 2,843 shares of PRCT stock, worth $203,473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,843
Previous 6,744
57.84%
Holding current value
$203,473
Previous $411,000
44.77%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
273Shares Held
39.4MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$249 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$110 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$89 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$84.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.19B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...